Emily M. Leproust
2020
Compensation breakdown
Non-Equity Incentive Plan | $452,192 |
---|---|
Option Awards | $4,192,726 |
Salary | $519,167 |
Stock Awards | $2,267,336 |
Other | $5,151 |
Total | $7,436,572 |
Leproust received $4.2M in option awards, accounting for 56% of the total pay in 2020.
Leproust also received $452.2K in non-equity incentive plan, $519.2K in salary, $2.3M in stock awards and $5.2K in other compensation.
Rankings
In 2020, Emily M. Leproust's compensation ranked 1,282nd out of 13,090 executives tracked by ExecPay. In other words, Leproust earned more than 90.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,282 out of 13,090 | 90th |
Division Manufacturing | 455 out of 5,624 | 92nd |
Major group Chemicals And Allied Products | 158 out of 2,257 | 93rd |
Industry group Drugs | 136 out of 1,957 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 38 out of 411 | 91st |
Leproust's colleagues
We found four more compensation records of executives who worked with Emily M. Leproust at Twist Bioscience Corp in 2020.
2020
Patrick Weiss
Twist Bioscience Corp
Chief Operating Officer
2020
Patrick Finn
Twist Bioscience Corp
Chief Commercial Officer
2020
James Thorburn
Twist Bioscience Corp
Chief Financial Officer
2020
William Banyai
Twist Bioscience Corp
Senior Vice President of Advanced Development and General Manager of Data Storage
News
January 6, 2023
January 4, 2022
January 7, 2021
June 14, 2019